---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-25-000005"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T07:43:00.818690+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lexicon Pharmaceuticals receives Nasdaq bid-price deficiency notice; 180 days to cure

## Summary
- Nasdaq notified Lexicon on Jan 3, 2025 that bid price closed below $1 for 31 consecutive business days.
- Company has until July 2, 2025 to regain compliance by closing at $1+ for 10 consecutive days.
- If not cured, Lexicon may seek a second 180-day period if it meets other listing standards; reverse split considered.
- Notice does not cause immediate delisting; company will monitor and evaluate options.
- No assurance that compliance can be regained or maintained.

## SEC filing metadata
- accession: 0001062822-25-000005
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/0001062822-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/lxrx-20250103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-25-000005
- JSON: https://secwatch.observer/filing/0001062822-25-000005.json
- Plain text: https://secwatch.observer/filing/0001062822-25-000005.txt

## Key facts
- Listing & Compliance Notices
  LEXICON PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: January 3, 2025, we received a letter (the “Notice”) from the Listing Qualifications staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of our common stock for the last 31 c
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/0001062822-25-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.